# PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema

> **NCT05056207** · NA · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 260 (actual)

## Conditions studied

- Lymphedema

## Interventions

- **OTHER:** Cohort I (patients receiving annual lymphedema screening
- **OTHER:** Cohort II (patients followed intensively for lymphedema)

## Key facts

- **NCT ID:** NCT05056207
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-11-17
- **Primary completion:** 2026-11-17
- **Final completion:** 2026-11-17
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05056207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05056207, "PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05056207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*